| 000 | 01106 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513210621.0 | ||
| 264 | 0 | _c20020411 | |
| 008 | 200204s 0 0 eng d | ||
| 022 | _a0964-3397 | ||
| 024 | 7 |
_a10.1054/iccn.2000.1476 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMacConnachie, A M | |
| 245 | 0 | 0 |
_aTemozolomide (Temodal) for treatment of primary brain tumours. _h[electronic resource] |
| 260 |
_bIntensive & critical care nursing _cFeb 2000 |
||
| 300 |
_a59-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xpharmacology |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDacarbazine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDrug Monitoring _xmethods |
| 650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTemozolomide |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tIntensive & critical care nursing _gvol. 16 _gno. 1 _gp. 59-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1054/iccn.2000.1476 _zAvailable from publisher's website |
| 999 |
_c10743042 _d10743042 |
||